A retrospective cohort study assessing differences between available LAMA/LABA FDCs on the risk of acute exacerbation and cardiovascular events in Patients with Chronic Obstructive Pulmonary Disease
Latest Information Update: 01 Dec 2022
At a glance
- Drugs Glycopyrrolate/indacaterol (Primary) ; Olodaterol/tiotropium bromide (Primary) ; Umeclidinium/vilanterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
Most Recent Events
- 01 Dec 2022 New trial record
- 26 Nov 2022 Results published in the Chest